Hypersensitivity - Schein 4/11/16 Flashcards
hypersensitivity
4 types
exaggerated response of the immune system to some antigen in a damaging way
- aka allergic reaction
4 types:
type I : IgE mediated hypersensitivity - ab (Th2)
type II : antibody-mediated cytotoxic hypersensitivity - ab (Th2)
type III : immune complex-mediated hypersensitivity - ab (Th2)
type IV : Delayed Type hypersensitivity - T cells (Th1)
type I hypersensitivity
immediate (minutes) = allergy (atopy)
-
initial exposure: sensitization → Th2 activation → IgE made
- IgE binds Fc receptor on mast cells and basophils, hangs out waiting for secondary exposure
-
secondary exposure: multivalent antigen causes cross-linking of surface IgEs → release of inflammatory mediators by mast cells, eosinophils, basophils
- mast cell pdts attract eosinophils (primary defense against parasites/worms/etc)
ex. hay fever, asthma, allergy to penicillin, expulsion of worms/insect infections
allergy mediators
primary (stored)
- histamine, serotonin (vascular permeability, smooth muscle contraction)
- eosinophil chemotaxis mediators
- neutrophil chemotaxis mediators
- protease (mucus secretion, connective tissue degradation)
secondary (synthesized)
- leukotrienes (vascular permeability, sm muscle contraction)
- prostaglandins (vasodilation, sm muscle contraction, platelet activation)
- bradykinin (vascular permeability, sm muscle contraction, pain)
-
cytokines (recruit immune cells, inflammation)
*
manifestations of allergy
symptoms: sneezing, coughing, wheezing, diarrhea
local anaphylaxis: allergic rhinitis, asthma, urticaria (hives), atopic dermatitis (eczema), angioedema (swelling of soft tissues)
late phase rxn: cytokines recruit eosinoiphils, neutrophils, lymphocytes → promotes infl
systemic anaphylaxis:
- disseminated mast cell activation → increased vasc permeability, constriction of sm muscle
- leads to extravasation of fluid ( → hypotension), constriction of airways, epiglottis swelling
skin test for allergy
small amt of allergen introduced via intradermal injection or superficial scratching
local mast cells degranulate → increased permeability and fluid leakage, vasodilation and increased blood flow
- wheal: swelling, local region of intense edema. appears white bc capillaries are occluded
- flare: larger surrounding areas of redness due to vasodil
RAST test for allergy
radioallergosorbant test
detects level of IgE
- allergens are coupled to beads
- patient serum is added → IgE binds beads
- radiolabeled anti-IgE is added, measured → IgE quantified
allergy shots
desensitization
introduce small amounts of antigen in increasing amounts over a period of time
goal: try to get isotype switching from IgE → IgA, IgG
- trying to get Tregs going to suppress Th2 cells that are forming IgE
- if it works; IgA and IgG will bind to and neutralize antigen when it’s encountered, prevent it from binding IgE → prevent it from setting off allergic rxn
hygiene hypothesis
modern day practice of hitting everything with antiseptics and avoiding all types of microbial contact → insufficient contact leading to insufficient stimulation of Th1 reactions
- results in imbalance of Th1/Th2 → more Th2 → processing of innocuous environmental agents as threats → allergic responses
theory: exposure to diverse environmental antigens may actually prevent sensitization to any particular one
type II hypersensitivity
antibody-mediated cytotoxicity
hours (vs Type I minutes)
IgM or IgG dependent → bind to antigens on cell surfaces
opsonization →
- phagocytosis by macrophages and neutrophils
- neutrophil recog and secretion of lytic enzymes (antibody-dependent cell-mediated cytotoxicity = ADCC)
- complement activation (MAC attack)
ADCC
antibody-dependent cell-mediated cytotoxicity
target cell is coated with antibodies → target cell is lysed by cytosolic effector cells
- NK cells
- macrophages
- neutrophils
no complement required!!!
but dependent on prior antibody response
type II hypersensitivites (rxns)
- transfusion reactions
- hemolytic disease of newborn (HDN)
- autoimmune diseases
- drug-induced hemolytic anemia
- antibiotics (cephalosporin, penicillin, streptomycin
- cell membrane is carrier for hapten-carrier complexes
*hapten: small molecule that can bind an antibody but is not immunogenic in and of itself
type III hypersentitivity
4-12 hours
immune complex disease : caused by circulating antigen-antibody complexes that can lodge in small vessels and filtering organs
- complexes = antigen + high-affinity IgG (lower affinity IgM)
mechanisms
1. large complexes are insoluble
- fix complement → phagocytosed
2. small complexes can get into tissues where they can cause probs
- not cleared as readily, can accumulate in blood, get deposited in vessels
3. complement C3a and C5a (anaphylatoxins)
- induce mast cell degranulation (IgG, not IgE)
- mediate inflammation response
- release cytokines, attracts neutrophils to come through and phagocytose and release lytic enzymes (tissue injury)
Arthus reaction
type III rxn
- acute response initiated by local deposition of Ag/Ab complexes
- 4-12 hours to develop
- immune complexes must form in situ → activate mast cells and neutrophils, activate complement
- develops more slowly than type I hypersensitivity, more quickly than type IV hypersensitivity
looks like wheal and flare! BUT takes hours to form
- pay attn to time course!
localized vs. systemic type III rxns
localized
- local vasculitis: deposition of immune complexes in dermal blood vessels
- insect bites
- drugs/vaccines
- intrapulmonary (inhaled bacterial spores, fungi (Farmer’s Lung), fecal proteins)
systemic
- serum sickness
- autoimmune diseases (rheumatoid arthritis, systemic lupus erythematosus)
example of arthus rxn
drunk pt who gets a laceration, needs a tetanus booster (no need for antiserum, bc already got vaccine 5 yrs ago)
pt struggles, shot thats supposed to be intramuscular is given intradermal
12 hours later → painful lesion.
what happened?
point of intramuscular protocol: let booster diffuse into lymphoid system so that antigen therein can trigger antibody-generation
intradermally injected shot cant diffuse out quickly → end up reacting with the antibody already present → localized type III hypersensitivity rxn